250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science Angel Investors in United States

A list of 50 angel investors that invest in Life science startups based in United states. We rank investors based on the number of investments they made in Life science companies from United states. We update this investor list every month.

Top 50 Life Science Angel Investors in United States

Investor Life Science United States investments
Sahin Boydas 5
Milad Alucozai 4
bumpkins profile 4
Chris Gibson 3
Erik Peterson 3
Darian Shirazi 3
Kevin Moore 3
Esther Dyson 3
Michael Chambers 2
Brian S. Cohen 2
Joshua Elkington 2
Zach Weinberg 2
Lars Fjeldsoe-Nielsen 2
James Hong 2
Ankit Jain 2
Patrick Collison 2
Nat Turner 2
Craig Mundie 2
Jay Zaveri 2
Patrick Yang 2
Peter Harris 2
Elad Gil 2
Kathryn Haun 2
Kevin Mahaffey 2
David R. Walt 2
Mei Z. 2
Sujay Jaswa 2
CJ Reim 2
Jim Greer 1
Willard Umphrey 1
Daniel Goldman 1
Ali Shaaban 1
Daniel M. Bradbury 1
Timothy A. Springer 1
Haig Farris 1
Nimi Katragadda 1
Douglas Hansen 1
Haig Farris 1
Noel Hall 1
Scott Garber 1
Stephen Siegel 1
Edward Kliphuis 1
Norman Sorensen 1
Aaron Levie 1
Lu Yoh-Chie 1
Leonardo DiCaprio 1
Avichal Garg 1
Nitesh Banta 1
Don Mattrick 1
Jonathan Milner 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Sahin Boydas Angel · San Francisco Bay Area, California, United States · 15 investments in the past 12 months
Sahin Boydas is the Head of RemoteTeam at Gusto.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • United States, Mexico, Spain
Portfolio highlights
  • Heyday AI — Manage all your social media messages in one place, including private messages and comments, with Hootsuite. Clean up your inbox with a free trial now!
  • Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
  • Wild Microbes — Wild Microbes is developing a microbial platform to produce faster and cheaper sustainable products from plastic to protein.
Milad Alucozai Angel · San Francisco, California, United States
Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
  • Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
  • Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.
bumpkins profile Angel
blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
  • Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
  • Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement
Chris Gibson Angel · Salt Lake City, Utah, United States · 3 investments in the past 12 months
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more
Investment focus
  • Biotechnology, Health Care, Life Science
  • Series A, Seed
  • United States, France, United Kingdom
Portfolio highlights
  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
  • Cradle — Design better proteins
Erik Peterson Angel · Chicago, Illinois, United States
Erik Peterson is the Founder at DormTrader.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Equity Crowdfunding, Series A
  • United States, Canada, Algeria
Portfolio highlights
  • Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
  • Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
  • Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.
Darian Shirazi Angel · San Francisco, California, United States · 18 investments in the past 12 months
Darian Shirazi is the General Partner of Gradient Ventures.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Medmo — Patients frequently have to wait longer, travel farther, and pay more for medical imaging than is necessary. That's something we're here to change.
  • Resend — Build, test, and send transactional emails at scale.
  • Infisical — Infisical is an open-source, end-to-end encrypted tool that supports developers in managing their teams, devices, and infrastructure's secrets and environment variables. Using an end-to-end encrypted method, it avoids the leakage of confidential information to version control and over insecure channels like email.
Kevin Moore Angel · Dallas, Texas, United States
Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Pre-Seed, Angel
  • United States, India, Canada
Portfolio highlights
  • Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
  • SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
  • Augmend — Record your screen. Capture knowledge. Scale your expertise and yourself. Record once, share forever.
Esther Dyson Angel · New York, New York, United States · 2 investments in the past 12 months
Esther Dyson - Founder @ Way to Wellville
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Funding Round
  • United States, Canada, Russian Federation
Portfolio highlights
  • Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
  • Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping & storage containers easy - get it delivered right to your door. Shop today!
  • Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.
Michael Chambers Angel · Fargo, North Dakota, United States
Michael Chambers is the Co-Founder at Agathos Biologics.Michael’s vision and leadership of Aldevron has resulted in several milestones including the 2004 acquisition of Genovac Antibody Technology of Freiburg, Germany; the 2009 expansion of protein production in Madison, Wisconsin; private equity transactions by TA Associates in 2017 and EQT in2020; and the purchase of Aldevron by Danaher for $9.6 billion in 2021. Michael is committed to ethical pharmaceutical development and his leadership will enable Agathos to create new paradigms in biotechnology to achieve these goals. Michael received Bachelor of Science degrees in biotechnology, chemistry, and microbiology from North Dakota State University.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Series A, Funding Round
  • United States
Portfolio highlights
  • Kytopen — Kytopen is pioneering a novel and non-viral process to engineer human cells for therapeutic applications in immuno-oncology and genetic disorders.
  • Erbi Biosystems — Erbi Biosystems is a transformative microfluidic bioprocess instrumentation company.
  • 64x Bio — 64x Bio builds a platform that increases the speed and scale of mammalian cell line discovery.The company uses a throughput discovery and screening platform and an integrated computational design loop, they develop new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specificfocus on those used for cell and gene therapies.
Brian S. Cohen Angel · New York, New York, United States
Considered one of the fathers of science & technology strategic communications - founded Technology Solutions, Inc. in 1983. Client list read like a who's who list of startup technology companies in computing, communication, software, education, and entertainment. Maintained a strategic communications partnership with Sony & IBMCorporation (10 years). Received the Gold CIPRA award in 1998 for the IBM Deep Blue/Gary Kasparov Chess Match. In 1996, TSI was recognized as the #1 fastest growing agency in the United States. Sold the company to The McCann Erickson World Group in 1997 and became the Vice Chairman. Created Focus Technology, an organization that provided qualitative research and instituted the RPM model of integrated strategic communications providing ultra-competitive technology clients the ability to quickly discover and leverage their key strengths as well as mitigate their destructive weaknesses.Brian was a pioneer in the founding of a number of the first computing publications including Computer Systems News and InformationWeek magazine. Now serves as Chairman of the New York Angels. He is very devoted to the New York City startup community.Developed the AIMS (Applied Internet Media Studies) Program, a senior/graduate level college semester program where students will be rigorously trained to use the internet professionally.Frequent speaker on strategic communication, entrepreneurism and early startup investing. Now writing a book for McGraw Hill - a new organizational product launch model.Received the Distinguished Alumnus Award, holds a Masters Degree in Science Communications from Boston University's School of Communications.
Show more
Investment focus
  • Software, SaaS, Mobile
  • Seed, Series A, Funding Round
  • United States, Israel
Portfolio highlights
  • Authorea — Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research. Its platform serves as a powerful document editor for researchers and provides collaborative editing, automatic citation formatting, tracking changes and it has the ability to make any document public or fully private that enablesresearchers to write documents together and attach references, figures, data, and source code. It improves how researchers work and make breakthrough discoveries by tackling one of the most important parts of the research cycle which is communication.
  • CourseHorse — CourseHorse is a provider of a learning platform used to centralize the learning opportunities. Its platform partners with providers of Spanish lessons, cooking courses, yoga classes, and other classes to create a single destination for people seeking personal interest education that enables people to increase ease and confidence in discovering thepath to personal enrichment.It was founded in 2011 and is headquartered in New York.
  • Boundless Mind — Thrive Global's mission is to end the burnout epidemic with sustainable, science-based solutions that unlock employee performance and enhance well-being through our behavior change technology.
Joshua Elkington Angel
Joshua Elkington
Show more
Investment focus
  • Biopharma, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Tierra Biosciences, Inc. — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
  • Tierra Biosciences — Speed, scale and simplicity with protein synthesis on-demand. Discover your portal to thousands of custom proteins. Get testable material with a single input.
Zach Weinberg Angel · New York, New York, United States
Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, Israel, Colombia
Portfolio highlights
  • Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
  • Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.
Lars Fjeldsoe-Nielsen Angel · London, England, United Kingdom
Lars Fjeldsoe-Nielsen is a Co-Founder & serves as a Partner at 2xN. Lars Fjeldsoe-Nielsen was General Partner at Balderton Capital in London from 2015-2021 through four funds. He joined after spending a decade in Silicon Valley where he was with Uber and Dropbox.Since 2012 his venture track record includes two IPOs (Uber, Dropbox) and 11acquisitions.Lars joined Balderton from Uber which he joined when the company was operating in less than 20 cities. His role as Vice-President resulted in strategic alliances. Lars joined Uber from Dropbox as one of the company’s first 25 employees. As Head of Mobile, his growth deals with Samsung and other mobile OEMs helped Dropbox reach its first 100 million users. Prior to that Lars held positions at Voicesignal (acq. Nuance), Skyhook Wireless (acq. TruePosition), Ness Technologies (acq. Opentable), 3Jam (acq. Skype) and T9 Tegic (acq. AOL). More than a billion people have used the software and services distributed as a result of mobile growth partnerships led by Lars.His venture investments include Voi (Raine), Labster (A16Z), Hiya (Ericsson), Cambridge Quantum Computing (HON), Hopin (A16Z), Opensea (A16Z), Yassir (YC), Beacon (Eric Schmidt), The org (Sequoia), Octant (A16Z), Zycada (Khosla), Monarch Money (Accel) and Kukua (Tencent), Dubsmash (acq. Reddit), Tempow (acq. Google), Rahko (acq. Odyssey Therapeutics), Pocket (acq. Mozilla), Blue Bottle (acq. Nestle), Marble (acq. Caterpillar).Lars, who is Danish-Portuguese, grew up across Africa and served with the Royal Danish Guards. He holds a MBA from London Business School, where he also serves on the Board of Trustees, an MSc from Oxford University Keble College and a BSc from King’s College, London. He lives in London with his wife and three children.
Show more
Investment focus
  • Software, Information Technology, Mobile Apps
  • Seed, Series A, Funding Round
  • United States, Denmark, United Kingdom
Portfolio highlights
  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • LiveFlow — The easiest way to bring financial data into your spreadsheet. Automate your finances, consolidate your accounts and collaborate in real-time. Try LiveFlow for free today!
  • Quantrol Ox — QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.
James Hong Angel · San Francisco, California, United States
James Hong
Show more
Investment focus
  • E-Commerce, Mobile, Internet
  • Seed, Series A, Angel
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Deep Infra — Deep Infra offers cost-effective, scalable, easy-to-deploy, and production-ready machine-learning models and infrastructures for deep-learning models.
  • Alchemy — Whether you're a beginner, working on a side project, or one of the largest teams in the blockchain space, Alchemy makes Ethereum development easy with enhanced APIs, node infrastructure, and developer tooling. Get started for free!
Ankit Jain Angel · San Francisco, California, United States
Ankit Jain is the Founder and CEO of Infinitus Systems.
Show more
Investment focus
  • Health Care, Medical, Hospital
  • Seed, Pre-Seed
  • United States
Portfolio highlights
  • RapidClaims — Rapid Claims helps businesses autonomously code medical charts, find up-coding opportunities, improve the CDI process and reduce denials.
  • Empower Sleep — Empower Sleep provides personalized sleep care online
  • Resilient Lifescience — Resilient Lifescience is developing a wearable medical device to detect and reverse opioid overdose
Patrick Collison Angel · San Francisco, California, United States · 5 investments in the past 12 months
Patrick Collison is a Content Strategist for Stripe.
Show more
Investment focus
  • Software, Financial Services, Information Technology
  • Seed, Series A, Series C
  • United States, United Kingdom, India
Portfolio highlights
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.
  • Rain Industries — Every wildfire starts small. Rain contains wildfires within 10 minutes of ignition with autonomous drones.
Nat Turner Angel · New York, New York, United States
Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.
Show more
Investment focus
  • Health Care, Software, Medical
  • Seed, Series A, Series B
  • United States, China, Colombia
Portfolio highlights
  • CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
  • Collectors — Helping collectors to pursue their passion.
  • Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Craig Mundie Angel
Craig Mundie is chief research and strategy officer of Microsoft Corp., reporting to CEO Steve Ballmer. In this role, he oversees Microsoft Research, one of the world’s largest computer-science research organizations, and is responsible for Microsoft’s long-term technology strategy. Mundie also directs a number of technology incubations, and workswith government and business leaders around the world on technology policy, regulation and standards.Mundie has spent much of his career building startups in various fields, including supercomputing, consumer electronics, education, healthcare and robotics. He joined Microsoft in 1992 to create and run the Consumer Platforms Division, which developed non-PC platforms such as the Windows CE operating system; software for the Handheld PC, Pocket PC and Auto PC; and early console-gaming products. Mundie also started Microsoft’s digital-TV efforts, acquiring and managing its WebTV Networks subsidiary, and built its fast-growing healthcare solutions business.Prior to his current role, Mundie served as Microsoft’s chief technical officer for advanced strategies and policy, working with Microsoft Chairman Bill Gates to develop the company’s global strategies around technical, business and policy issues. Another long-standing focus for Mundie is privacy, security and cyber-security. He initiated Microsoft’s Trustworthy Computing initiative, which has leveraged new software-development practices to significantly improve the security of the company’s products.For more than a decade, Mundie has also been Microsoft’s principal technology-policy liaison to the U.S. and foreign governments, with an emphasis on China, India and Russia. He has served on the U.S. National Security Telecommunications Advisory Committee and the Markle Foundation Task Force on National Security in the Information Age. In April 2009 Mundie was appointed by President Barack Obama to the President’s Council of Advisors on Science and Technology.Mundie started his career in 1970, working on operating-system development for the Data General NOVA at Systems Equipment Corp. (SEC) while still studying at Georgia Tech. SEC was subsequently acquired by Data General Corp., where Mundie went on to develop the INFOS data-management system. In 1977 Mundie moved to Data General’s advanced development facility in Research Triangle Park, N.C., ultimately becoming its director. In 1982, Mundie was one of three co-founders of Alliant Computer Systems Corp., which developed vector-parallel mini-supercomputers. He held a variety of positions at Alliant before becoming CEO. The company shut down in 1992.Mundie holds a bachelor’s degree in electrical engineering and a master’s degree in information theory and computer science from Georgia Tech. Mundie enjoys traveling and spending time on his boat. He is married, with one married daughter.
Show more
Investment focus
  • Life Science, Chemical, Genetics
  • Seed, Series B, Series C
  • United States
Portfolio highlights
  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Exicure — Exicure is Formerly Known as AuraSense Therapeuticsis. Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets. Our 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. Our lead programs address diseases from inflammatorydisorders to oncology.SNA constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. SNA constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. Moreover, SNAs can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease.
Jay Zaveri Angel · San Francisco Bay Area, California, United States
Jay Zaveri has been serving Social Capital as a partner since November 2015. He also founded CloudOn and Future Thought Productions.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United States, Japan, Canada
Portfolio highlights
  • Cleerly — Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.Throughthese data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
  • BitClout — BitClout is a platform owned by its users. Bitcoin is decentralizing money, BitClout is decentralizing social media.
  • Kingdom Supercultures — Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits. It re-assembles nature's microbes into new combinations, creating plant-based foods that taste like dairy, low-alcohol beverages with full flavor, and natural preservatives that work as well as artificial ones.They workwith clients across diverse industries including food, beverage, personal care, beauty, and more. Their technology comprises an expansive biobank of GRAS microbial strains, high-resolution strain characterization, and new algorithms for predicting and assembling microbial communities.
Patrick Yang Angel · San Francisco, California, United States
Patrick Yang, General Partner at Amity Ventures, has led the firm’s investments in CaptivateIQ, Evisort, Flick, MoQuality, TruePill, and Vowel. He sits on the boards of Evisort and MoQuality. His primary areas of investment focus include AI, consumer, logistics, mobility, and software. Patrick co-founded Amity Ventures with CJ Reim in 2017 afterthe two worked together at Highland Capital Partners.Prior to Amity, Patrick was a Vice President at Highland, where he sourced the firm’s investment in nuTonomy, an autonomous vehicle startup acquired by Delphi one year later for $450M. Patrick is from the Bay Area and holds a B.S. in Business Administration with a concentration in Engineering Leadership from University of California, Berkeley.Pat currently serves on the board of Advancing Women in Product, a non-profit that empowers women to enter and succeed in product management roles. In his free time, he enjoys hiking and eating in the San Francisco area, and attending sporting events—especially Warriors, 49ers, and Giants games.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Series A, Seed, Series B
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Innerwell — Innerwell combines personalized guidance from licensed therapists like you with the expansive power of psychedelics to treat anxiety and depression.
Peter Harris Angel
Peter Harris
Show more
Investment focus
  • Life Science, Biotechnology, Health Diagnostics
  • Seed
  • United States
Portfolio highlights
  • CND Life Sciences — Our suite of neurodiagnostic tests give clinicians access to objective pathological insights on diseases that are often difficult to diagnose
Elad Gil Angel · San Francisco, California, United States · 26 investments in the past 12 months
Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Series B
  • United States, United Kingdom, Israel
Portfolio highlights
  • Succinct — The easiest way to discover, develop, and deploy ZK.
  • Fieldguide — Fieldguide is a workflow automation and collaboration software platform for audit, attestation, assurance, and advisory practices and firms.
  • Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.
Kathryn Haun Angel · San Francisco, California, United States
Katie Haun is a General Partner at Andreessen Horowitz. She serves on the boards of Coinbase and HackerOne and has invested in and advised tech companies from seed to Series E stage. Katie teaches a management course at Stanford Business School and previously taught cybercrime at Stanford Law School. Previously, she spent a decade as a federalprosecutor with the U.S. Department of Justice focusing on fraud, cyber, and corporate crime alongside agencies including the SEC, FBI, and Treasury. She created the government’s first cryptocurrency task force and led investigations into the Mt. Gox hack and the corrupt agents on the Silk Road task force. She also prosecuted RICO murders, organized crime, public corruption, gangs, and money laundering, and held senior policy positions at headquarters in both the National Security Division and Attorney General’s office where her portfolio included antitrust, tax, and national security. Katie clerked for U.S. Supreme Court Justice Anthony Kennedy and is an honors graduate of Stanford Law School.
Show more
Investment focus
  • Blockchain, Financial Services, FinTech
  • Funding Round, Seed, Series A
  • United States, United Kingdom
Portfolio highlights
  • dub — The first Copy-Trading platform for stocks. Copy anyone's investments. For free. Regulated Broker-Dealer member FINRA and SIPC & FDIC insured.
  • Aptos — Building products, applications, and tooling on the Aptos blockchain. Bringing the benefits of decentralization to the masses.
  • Primer — Primer is the world's first community built for curious and ambitious kids to find and explore their interests together.
Kevin Mahaffey Angel · San Francisco, California, United States · 7 investments in the past 12 months
Kevin Patrick Mahaffey is the Founder of Lookout and SNR. He is also the Executive Chairman of Stork Club and an Investor.
Show more
Investment focus
  • Software, SaaS, Enterprise Software
  • Seed, Series A, Pre-Seed
  • United States, Canada, India
Portfolio highlights
  • dcbel — dcbel's mission is to deliver energy that lets people live a life without compromise.dcbel™ (formerly known as Ossiaco) sits at the nexus of residential solar power, electric vehicle charging, the smart home, and customer-centric utilities. The dcbel team has a proven history of rethinking energy distribution for everything from largeutility customers to distributed energy resource providers.dcbel's AI-driven sustainable technologies enable people to leverage solar energy to power their cars, their homes, and their lifestyles.dcbel has numerous worldwide patents in power electronics and power conversion and is backed by a number of globally respected investors.
  • Monomer Bio — Monomer Bio provides solutions for laboratory automation. We specialize in automating biology research with a focus on cell culture. Automate your cell culture workflows by leveraging the Monomer automation software platform in conjunction with readily-available hardware and instrumentation.
  • Saleor Commerce — A headless, GraphQL-first e-commerce platform delivering ultra-fast, dynamic, personalized shopping experiences. Find out why developers love it.
David R. Walt Angel · Boston, Massachusetts, United States
David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
  • Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
  • Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Mei Z. Angel · San Francisco Bay Area, California, United States · 2 investments in the past 12 months
Mei Z. is the Co-Founder and Partner at Alloy Fund. Mei was a Former Associate at Romulus Capital, and studied at Massachusetts Institute of Technology.
Show more
Investment focus
  • Biotechnology, FinTech, Software
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Singapore
Portfolio highlights
  • SynthLabs — research lab for transparent, auditable AI alignment
  • Essential AI — Essential AI aims to build software for enterprises to use large language models, the core software of a new artificial intelligence system.
  • Shennon Biotechnologies — Shennon Biotechnologies analyzes and manipulates a massive number of cells on the single-cell level to develop more effective treatments for human diseases. It functionally profiles millions of immune cells to find the best targets for cancer immunotherapy.
Sujay Jaswa Angel · San Francisco, California, United States
Sujay Jaswa is founder and managing partner at WndrCo, a holding company that invests in and acquires consumer technology businesses. He serves as Chairman of Aura, Twingate, VPN Super, and is a Director of The Infatuation. Board member of Vy Global Growth (Nasdaq: VYGG). Advisor at Seven1 Sports & Entertainment Agency. He is also a lecturerat the Stanford Graduate School of Business. He formerly served as business founder, vice president of business, and CFO of Dropbox from 2010 to 2015. At Dropbox, Sujay created and led the global business and finance organization. He has a Bachelor’s degree in Economics from Princeton University and an MBA from Harvard Business School.
Show more
Investment focus
  • Software, Media and Entertainment, Internet
  • Seed, Series B, Series A
  • United States, Spain, Germany
Portfolio highlights
  • HUBUC — A single API-platform that allows any business to embed financial services capabilities into their products. 
e.g Uber can issue branded credit cards for all Uber drivers and Walmart provides customers a simple way to better manage and control their everyday finances, with no regulatory burden or compliance requirements in a few weeks.
  • point.me — Stop wasting your points! Find the best flight deals with the fewest points and make your dream trip a reality. Start your first search for free today!
  • Fireside — Fireside is the first interactive streaming platform that invites you to be part of the show. Co-founded by Falon Fatemi and Mark Cuban the media and entertainment networks of the future are emerging on Fireside.
CJ Reim Angel · San Francisco, California, United States
CJ Reim is a co-founder of Amity Ventures and an active investor in Avochato, Carta, Ouster, Talkdesk, and more than 15 other growing technology businesses. CJ is currently focused on investments in software, fintech, and consumer sectors, and represents Amity on the boards of Avochato and MaintainX.Prior to Amity, CJ was a Vice President on theinvestment team at Highland Capital Partners, where he focused on technology investments across all stages of company growth. He also led the Summer@Highland entrepreneurship program which, over its nine-year history, has mentored 50 student-led startups from inception. CJ is originally from Minnesota and holds a B.S. in Management with concentrations in Finance and Information Systems from Boston College. Outside of Amity, CJ enjoys CrossFit, freediving, and downhill skiing.
Show more
Investment focus
  • Robotics, E-Commerce, Internet
  • Series A, Seed, Series B
  • United States
Portfolio highlights
  • Athelas — Our breakthrough technologies provide clarity on a patient's most important health metrics, all while increasing revenue for your practice.
  • Burrow — Meet Burrow. We make clever, uncompromising furniture and other nice things fit for modern life at home. From our comfortable, customizable sofas, sectionals, loveseats, and armchairs to our fashionable, functional rugs and tables, and five unique collections of decorative pillows and throw blankets, Burrow is the perfect place to start when shopping for your home.
  • Arkive — Arkive is a web3 museum of real world items, curated by a community of passionate hobbyists, collectors, artists, designers, and creators.
Jim Greer Angel · San Francisco Bay Area, California, United States
Jim Greer is the Chief Executive Officer at Bash. He was the co-founder and Chief Executive Officer of Kongregate. Before founding Kongregate in June 2006, Jim was Technical Director for Pogo at Electronic Arts. He has worked in the game industry since 1991.
Show more
Investment focus
  • Health Care, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Vium — Vium's Digital Vivarium offers high precision animal models with low-touch non-invasive monitoring for improved study accuracy and reproducibility.
Willard Umphrey Angel
Bill is the Chairman and Co-Founder of the Pear Tree Funds, the President of Pear Tree Investment Advisors, Inc., and the Chairman of U.S. Boston Capital Corporation. He has over 40 years of experience in the finance and investment management business.Bill holds the Chartered Financial Analyst (CFA) designation and is a member of the CFAInstitute and the Boston Security Analysts Society. He obtained his JD from Harvard Law School, an LLM in taxation from Boston University School of Law, a Masters in Personnel Administration from George Washington University, and a BS with distinction from the United States Naval Academy in Annapolis, Maryland.
Show more
Investment focus
  • Analytics, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Daniel Goldman Angel · San Francisco, California, United States
Daniel Goldman Managing Partner of Ignition Angels/Keystone CatalystsA pioneer in online gaming and online communities, Daniel has a passion for applying technology to real world problems. He studied cognitive neuroscience at Columbia and became COO and VP PD at Posit Science, with Dr. Michael Merzenich, the world leading expert onneuroplasticity. There he incorporated the latest understanding of reward systems, neuroplasticity and the science of play into products for cognitive rehabilitation. Currently an angel investor, Daniel’s interest is for a world where everyone has ubiquitous access to opportunity, both social and economic, as well as freedom of thought.
Show more
Investment focus
  • Chemical, Biotechnology, Video
  • Seed, Series A, Convertible Note
  • United States, United Kingdom
Portfolio highlights
  • Chai — Chai allows anyone to detect anything, anywhere with DNA, transforming biotech into an everyday productivity tool. Chai's Real-Time PCR and qPCR instruments are as accurate as a lab test, but cost 10x less, and are easy enough for anyone to use. Chai also develops PCR Master Mixes for the detection any pathogen, bacteria, virus, allergen,gene, species, or DNA tracer on-site at the point of need.Chai is impacting large industries such as food, agriculture, research, education, and security, while providing new solutions to combat consumer fraud, protect the environment, improve global health, and make small businesses like microbrewers more profitable.
  • Grit Media — Grit is a sports media start-up creating original digital videos for Gen Z.
  • Advanced Ionics — Advanced Ionics has created an electrolyzer that allows industrial hydrogen users to produce green hydrogen for less than $1/kg.
Ali Shaaban Angel · Cairo, Al Qahirah, Egypt
Ali Shaaban has been a pioneer in the digital advertising and communications industry for more than 18 years, founding the award-winning full-fledged creative digital agency Icon Creations back in 2003 when the industry was at its infancy stage. Since then, Ali Shaaban has built strong long-term relationships and a strategic network with most ofthe leading automotive brands in Egypt and the Middle East, where he established a solid track record of delivering top-notch digital products & services that stood the test of time. Driven by passion for excellence and an always-on personalized approach to satisfying his partners, Ali Shaaban is the quintessential digital partner to have on your side in the automotive industry today.His automotive portfolio includes Alfa Romeo, Bentley, BMW, Castrol, Citroën, Ferrari, Fiat, Ford, Hyundai, JAC, Jaguar, Jeep, KIA, Land Rover, Maserati, Mazda, MINI, Mitsubishi, Nissan, Peugeot, Pirelli, Renault, Seat, Subaru, Toyota, Volkswagen and more. Aside from being a digital pioneer, Ali Shaaban is also an angel investor and serial supporter of emerging innovative startups and fresh business ideas, venturing into several sectors to contribute in making a sustainable impact on the local and regional economies. His latest investments have tapped into the Fintech sector with rising companies such as Paynas (https://Paynas.com), Oxygen (https://oxygen.us/), Dfin Holding (https://www.dfinholding.com/) , and Kiwe wallet (https://kiweapp.com/) as well as the Media and AI sector with Speakol (https://speakol.com/) , NU Digital Awards (https://nudigitalawards.com/) and Nanotronics (https://nanotronics.co/ ).Ali Shaaban believes in always taking the next step forward in his extensive career, and using his core values and commanding personality as motivation, he has paved an impressive path over the years that will certainly lead towards an even more diverse and fruitful future.
Show more
Investment focus
  • Financial Services, FinTech, Banking
  • Series A, Seed, Pre-Seed
  • Egypt, United States, Kenya
Portfolio highlights
  • ImaliPay — ImaliPay is a financial health platform offering financial products to freelancers and blue collar gig workers in partnership with gig platforms.
  • QuadriBot — QuadriBot is an engineering company specializing in the design and development of electronics and automation technology, real-time systems and the development of IT and electronic solutions around smart transportation issues. We focus on robotics and autonomous vehicles as well as any mobile platfo.
  • Nanotronics Imaging — At Nanotronics we provide customized solutions for automated optical inspection, process control, and security. Learn more about what we can do for you.
Daniel M. Bradbury Angel · San Diego, California, United States
Daniel M. Bradbury is Director at Liquid Grids.
Show more
Investment focus
  • Life Science, Biotechnology
  • Series A
  • United States
Portfolio highlights
  • Alume Biosciences — Alume is a biotechnology company, developing nerve-targeted pharmaceutical agents for surgical and therapeutic use. The company's first product, ALM-488, is a fluorescently labeled peptide-dye conjugate that makes human nerves "glow," helping surgeons reduce injury to critical nerves during surgery. During surgery, inadvertentinjury to nerves leads to loss of function, including paralysis, numbness, and decreased quality of life. Alume intends to develop agents including ALM-488 to be used as an adjunct during surgery to help surgeons see nerves better compared to current visualization with white light alone. Alume's technology has the potential to improve the accuracy of nerve identification, decrease operative time, and lead to better outcomes for patients.
Timothy A. Springer Angel · Cambridge, Massachusetts, United States
Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Series A, Series B, Seed
  • United States, Canada
Portfolio highlights
  • Prenuvo — Prenuvo offers MRI scanning systems that help in early detection of cancer and other diseases.
  • Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
  • Tectonic Therapeutic — Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).
Haig Farris Angel
A pioneer of the venture capital industry in Canada, Haig co-founded Ventures West in 1968 and spent twenty-five years working to establish the venture capital industry in Canada. Since retiring from the firm he founded, Haig has become one of the most active and successful technology angel investors on theWest Coast. He has been instrumentalin the creation, growth, and success of dozens of technology companies and careers spanning four decades. Haig has served as co-founder, chair, and director of many high-profile companies, university and industry associations, and has been honoured by the Science Council of BC and the BC Technology Industries Association with awards for lifetime achievement and contribution to technology on Canada’s West Coast.
Show more
Investment focus
  • Life Science, Biotechnology, Bioinformatics
  • Pre-Seed
  • United States
Portfolio highlights
  • Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
Nimi Katragadda Angel · New York, New York, United States
Nimi Katragadda is an investor at BoxGroup, which is a seed stage venture fund that invests in entrepreneurs building companies with visions to create the next generation of category defining businesses. Prior to joining BoxGroup, Katragadda worked at Google and J.P. Morgan. She holds a MBA from Harvard Business School and a BA in Economics fromHarvard.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Pre-Seed, Series B
  • United States
Portfolio highlights
  • Ansa — The closed loop platform built for your customers.
  • Prime Discoveries — Prime Discoveries develops rapid, novel diagnostics for COVID (Omicron) that can help laboratories scale and test millions of samples.
Douglas Hansen Angel · New York, New York, United States
Douglas B. Hansen is a co-founder of Redwood and served as Redwood’s President from 1994 through 2008. Mr. Hansen retired from his position as President of Redwood at the end of 2008. Mr. Hansen has been a director of Redwood since 1994. Mr. Hansen serves on the Board of Directors of Four Corners Property Trust, Inc., a publicly traded real estateinvestment trust. Mr. Hansen also serves on the board of River of Knowledge, a not-for-profit institution. Mr. Hansen holds a B.A. in Economics from Harvard College and an M.B.A. from Harvard Business School.
Show more
Investment focus
  • Analytics, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Haig Farris Angel
Haig Farris is one of Canada's best-known venture capitalists and experts in high-technology start-ups and turn-arounds, with a varied 30+ year history of involvement, commitment, and management. He has a law degree from the University of Pennsylvania. He is co-founder and former Executive Chair of the Board of Directors of D-Wave, and he isthe President of Fractal Capital, a private venture capital company financing high technology start-ups and resource service technology companies.Previously, Dr. Farris was a co-founder and partner of the Ventures West Management group of venture capital funds (1972-1990). In 2001, he received the British Columbia Technologies Industry Association's (BCTIA) Bill Thompson Award.He was awarded an Honorary Doctor of Laws degree from UBC in 1997 and named A Pioneer of Innovation by the Vancouver Board of Trade in 2001.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Pre-Seed
  • Canada, United States
Portfolio highlights
  • Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
  • Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Noel Hall Angel
Noel Hall is the Director of Corporate of Wellcome Trust. He is a former Board Director, Co-founder, and President of Aspreva Pharmaceuticals Corp. He attended the University of London.
Show more
Investment focus
  • Biotechnology, Genetics, Life Science
  • Seed, Angel
  • Canada, United States
Portfolio highlights
  • Epistemic AI — At Epistemic AI we are building the next generation of tools to accelerate biomedical research with AI and NLP.We are a group of senior scientists and engineers from the likes of Google, New York University, Stanford and more. We are dedicated to enabling advances in biomedical research and practice with AI and NLP.We are creating a movement ofpeople enthusiastically committed to a new vision for the future of biomedical research and we hope you want to join us.
  • Incisive Genetics — IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular geneticdiseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
Scott Garber Angel · Baltimore, Maryland, United States
Scott Garber is the Managing Partner of Early Light Ventures. He attended The George Washington University School of Business.
Show more
Investment focus
  • Software, Information Technology, Cyber Security
  • Seed, Pre-Seed, Series A
  • United States
Portfolio highlights
  • Ethix360 — ETHIX360 provides Compliance as a Service (CaaS); a simple, affordable answer to employee ethics communication and human resources case management.
  • Ash & Erie — Men's clothes designed from scratch for shorter men 5'8" and under. Find men's casual and formal clothing from button-downs, t-shirts, sweaters, denim jeans, chinos, and more. FREE Shipping, Exchanges, and Returns.
  • Outlogic — Outlogic is a provider of location data for the retail, real estate, and financial markets. Outlogic has exemplified high standards and best practices for the collection and use of location data while still allowing companies to develop disruptive tools built on a foundation of quality data.
Stephen Siegel Angel · New York, New York, United States
Stephen Siegel is Chairman of Global Brokerage at CBRE, the world’s largest real estate services company. In that capacity, he advises major corporations and property owners on a broad range of real estate issues. Mr. Siegel is widely regarded in commercial real estate circles as one of the industry’s most talented and prolific professionals. Hewas featured in the Urban Land Institute’s book, Leadership Legacies: Lessons Learned from Ten Real Estate Legends. Mr. Siegel was honored with Commercial Property News’ Lifetime Achievement Award and named by Crain’s as one of the 100 Most Influential Business Leaders in New York City. Prior to the merger with CBRE, as Chairman and CEO of Insignia/ESG, Mr. Siegel was largely responsible for masterminding the global expansion of the firm, nationwide as well as throughout Europe, Japan, Hong Kong, China, Thailand and Latin America. In that role, he also managed a group that completed approximately $2 billion in co-investments in a wide range of U.S. office, residential, hotel and retail real estate portfolios. Throughout his distinguished career, Mr. Siegel has arranged transactions for some of the nation’s most prominent corporate clients, among them, J.P. Morgan Chase & Co.; Sidley Austin Brown & Wood LLP; Fried Frank Harris Shriver & Jacobson LLP; Amerada Hess Corp.; Sanford C. Bernstein & Co.; Swiss Reinsurance; MetLife; Cerberus Capital Management; and Akin, Gump, Strauss, Hauer & Feld LLP. Websites featuring him: https://www.tenement.org/development_news/stephen-siegel/,
Show more
Investment focus
  • Medical, Life Science, Biotechnology
  • Seed
  • United States
Portfolio highlights
  • Gift of Life Biologics — Gift of Life Biologics powers cell and gene therapy research and commercialization with high quality, consistent, cost-effective and timely starting material.
Edward Kliphuis Angel · Amsterdam, Noord-Holland, The Netherlands
Edward Kliphuis - Partner @ Sofinnova Partners
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Series C, Seed
  • United States, France, Israel
Portfolio highlights
  • BioCorteX — BioCorteX is a techbio that applies deep technology to deliver effective therapeutics and de-risk the pharma pipeline by leveraging the synergy between drugs and bacteria
  • Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
  • Padlock Therapeutics — Padlock is developing medicines targeting protein-arginine deiminases (PADs), enzymes with an important role in the generation of autoantigens, inflammation,and immune complexes in autoimmune diseases. Padlock intends to explore the full biological and therapeutic footprint of protein deimination by PADs.Padlock was founded by scientists at TheScripps Research Institute and members of the Atlas Venture Life Sciences Team. Padlock's investors include Atlas Venture, Johnson & Johnson, and MS Ventures.Padlock is a seed company operating out of the Atlas Venture office in Cambridge MA.
Norman Sorensen Angel · Des Moines, Iowa, United States
Norman Sorensen who is a Class II director, joined the Board of Directors in March 2015. He is a member of the Company’s Finance, Risk Management and Audit Committee. Mr. Sorensen formerly served as chairman of the International Insurance Society, Inc., a professional organization for the insurance industry, from January 2010 until June 2013. Mr.Sorensen has served as a director of the International Insurance Society, Inc. since January 2005. Previously, from November 2011 until December 2012, he was chairman of the International Advisory Council of Principal Financial Group, Inc., a global financial investment management company. He was chairman of Principal International, Inc., serving from June 2011 to October 2012, and president and CEO of International Asset Management and Accumulation of Principal International, Inc., serving from January 2001 to June 2011. Mr. Sorensen has served as a director of Encore Capital Group, Inc., a consumer banking company, since November 2011. Mr. Sorensen also served as a director of Sara Lee Corporation, an American consumer-goods company, from January 2007 to November 2011. He has served as executive vice president of both Principal Financial Group Inc. and Principal Life Insurance Company, a life insurance company, since January 2007, and held a number of other senior management positions since 1998. Mr. Sorensen also served as chairman of the U.S. Coalition of Service Industries, a leading forum for the services sector, from January 2003 to March 2005. Mr. Sorensen served as a senior executive of American International Group, Inc., an insurance services company, from September 1989 to December 1998. He also formerly served as chairman and director of DE Master Blenders, from December 2011 until September 2013.
Show more
Investment focus
  • SaaS, FinTech, Analytics
  • Seed
  • United States
Portfolio highlights
  • Solidus Labs — The first automated, comprehensive and testable market surveillance and risk monitoring hub tailored for digital assets
  • Thrive Bioscience — Thrive Bioscience is commercializing a family of instruments and software that provide imaging, analytics, and automation to significantly improve cell culture and the analysis of live cells. Thrive’s instruments empower biologists to deliver consistent, reproducible results by leveraging microscopy, robotics, fluidics, and other fields, to captureimages and data and provide analysis, reports, guidance, documentation, and a database on the cells and on cell culture processes.
Aaron Levie Angel · San Francisco Bay Area, California, United States
Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Series B
  • United States
Portfolio highlights
  • Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
  • BoomPop — Work culture resources, virtual event inspiration, team building ideas, and fresh perspectives on the future work, brought to you by the BoomPop team.
  • Superblocks — Superblocks is the fast, easy and secure way for developers to build custom internal tools fast. Connect your databases & APIs. Drag and drop UI components. Extend with Python or Javascript. Deploy in 1-click. Secure and Monitor using your favorite tools
Lu Yoh-Chie Angel
Lu, the founder of Biosensors International Group Ltd, was its chairman and CEO from its inception to 2008. He retained his leadership position as chairman of the Group since January 2008. Today BIG is one of the leading medical device companies with a market cap in excess of $1.6B.
Show more
Investment focus
  • Medical, Health Care, Artificial Intelligence
  • Seed, Series A
  • United States
Portfolio highlights
  • Bot MD — Bot MD Care is an A.I. clinical chat assistant. Our A.I. integrates hospital information to provide instant answers to doctor queries and helps automates patient monitoring.
  • BioTrillion — We so often think of Healthcare as an industry, that we tend to forget about Healthcare as a purpose. Globally and annually, trillions of dollars are ineffectively spent on healthcare and trillions of life data points are ineffectively connected to insights about our health. There is a better way.BioTrillion is a little startup with boldambitions to more efficatiously and scalably advance Healthcare – via Digital Biomarkers.Every human generates massive amounts of life data that will unlock novel health insights & applications. BioTrillion is developing a mobile health technology platform called BioEngine4D™ – for digitally detecting dangeous drugs, digitally detecting developing diseases, and data driven drug development – by measuring data from life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back for life.BioTrillion, Inc. is headquartered in San Francisco, CA and is reimagining Life Sciences through the fundamental principles of many sciences.Our mission is to enable consumer smart devices to empower ordinary consumers with extraordinary health insights. Advances in technology have amplified our individual capabilities in many ways, and healthcare should be no exception.Website: www.biotrillion.com Contact: contact@biotrillion.com Jobs: https://www.biotrillion.com/opportunities Application: https://biotrillion.typeform.com/to/wSvoKI
Leonardo DiCaprio Angel · Los Angeles, California, United States · 2 investments in the past 12 months
Leonardo DiCaprio is an American actor and film producer. He has been nominated for three Academy Awards and nine Golden Globe Awards. He won the Golden Globe Award for Best Actor for his performance in The Aviator (2004), and has been nominated by the Screen Actors Guild, Satellite Awards, and the British Academy of Film and Television Arts. Acommitted environmentalist, DiCaprio has received praise from environmental groups for his activism. At the 2007 Oscar ceremony, DiCaprio and former Vice President Al Gore announced that the Academy Awards had incorporated environmentally intelligent practices throughout the planning and production processes, and on July 7, 2007, DiCaprio presented at the American leg of Live Earth.
Show more
Investment focus
  • Food and Beverage, Food Processing, Health Care
  • Series A, Funding Round, Seed
  • United States, Israel, Switzerland
Portfolio highlights
  • Polestar — Wir stellen Performance-Elektroautos her. Unser Ziel: eine bessere Zukunft durch Innovationen.
  • ID Genève — We make watches that reflect the values and principles of people who are committed to fight climate change and who wish to have a positive social and environmental impact. The materials used are circular and have a lower carbon footprint than the industry average.
  • NUVIEW — Explore NUVIEW's LiDAR satellite technology, revolutionizing Earth observation with annual global mapping, unrivaled coverage, and cutting-edge data.
Avichal Garg Angel · Stanford, California, United States · 3 investments in the past 12 months
Avichal is Managing Partner at Electric Capital. He is a serial entrepreneur and technology executive. Avichal sold two companies and was most recently Director of Product at Facebook, which acquired his company Spool in 2012. He previously worked at Google on search ranking and ads ranking, is part-time at YCombinator, and an active angelinvestor.Avichal's firm, Electric Capital, focuses on cryptocurrencies that are rooted in technological utility. Electric performs deep technological diligence, such as compiling code, profiling nodes, and analyzing blockchains with in-house software. The founders of Electric have started and sold five companies, have been investing in cryptocurrencies since 2013, and are investors in Anchor, Bitwise, Chia, Coda, dYdX, Dfinity, Oasis, Thunder and many other crypto projects.
Show more
Investment focus
  • Software, Blockchain, Financial Services
  • Seed, Series A, Pre-Seed
  • United States, Canada, Mexico
Portfolio highlights
  • Key — Key provides a unique method to making significant professional relationships while also promoting career advancement, financial well-being, and work-life balance
  • Matic — The world's most advanced floor cleaner. Your home's best helper.
  • Magrathea — Magrathea Metals is a mining company that unlocks centuries of growth in human civilization by reducing the socioenvironmental impacts.
Nitesh Banta Angel · New York, New York, United States · 7 investments in the past 12 months
Nitesh Banta is the Co-Founder & CEO at B12.
Show more
Investment focus
  • Software, Information Technology, FinTech
  • Seed, Series A, Pre-Seed
  • United States, Canada, United Kingdom
Portfolio highlights
  • Yumari — Wholesale Buying from Latin America Made Easy
  • Beam — Take control of your finances, all in one place. Say goodbye to paperwork, spreadsheets, and hours of manual data entry.
  • K2 Space — By breaking the historic correlation between mass and cost, the K2 Space satellite bus offers the capabilities of large satellites at the price point of small satellites. A multi-orbit spacecraft for use across commercial, scientific and defense missions.
Don Mattrick Angel · Victoria, British Columbia, Canada
Don Mattrick is Chief Executive Officer of Zynga, a social game services company headquartered in San Francisco, California. His mandate is to further the company’s mission of connecting the world through games. As an industry-leading executive in entertainment, games, and consumer products, Mattrick has firmly established himself during a 30-yearcareer as a world-class leader of game, platform, and team development.Before joining Zynga in 2013, Mattrick, 49, spent six years at Microsoft – the last three as President of the Interactive Entertainment Business. He was responsible for leading the team that grew Microsoft’s Xbox 360 global installed base by 700 percent, to nearly 75 million consoles, and Xbox Live membership from 6 million to nearly 50 million subscribers in 41 countries. During his tenure at Microsoft, Mattrick also oversaw businesses and services focused on consumer products, including PC and mobile interactive entertainment and the groundbreaking Kinect entertainment products; the Kinect was released in November 2010 and set a Guinness World Record for the fastest-selling consumer electronic device in its first 60 days. Mattrick is widely recognized for transforming the Microsoft Interactive Entertainment Business from one that was operating at a loss into a sustained and profitable business.Prior to Microsoft, Mattrick served in several leadership positions at Electronic Arts, most recently as President of Worldwide Studios, in which capacity he oversaw EA's global studios and research & development in several major sites, including Redwood Shores, Calif. (Silicon Valley), Los Angeles, EA Tiburon in Florida, EA Canada in Vancouver, British Columbia, and Montreal, and EA U.K. During his 15-year career at Electronic Arts, Mattrick helped develop and scale the company’s leading global game franchises and brands, including Need for Speed, FIFA, and The Sims.Mattrick founded his first company, Distinctive Software, at age 17; it was acquired by Electronic Arts in 1991 and subsequently became EA Canada.Over the years, Mattrick has been broadly recognized for his work in the technology industry. In 2011, he was featured in Fortune Magazine as one of the "Smartest People in Tech,” highlighting his leadership in growing the Xbox business, including the pivotal role he played in driving new consumer innovations such as Kinect; and in May 2012, he was named one of CNN Money’s top 10 “brilliant technology visionaries.”Raised in Vancouver, British Columbia, Mattrick is married with two children. In acknowledgement of his role in building the interactive entertainment business in Canada and the active development of industry links with the University of British Columbia, Mattrick received the UBC Award as an Honorary Fellow from the Sauder School of Business and was awarded the highest honor Simon Fraser University can bestow, the Doctor of Laws. He has served on several public and private boards, including the advisory board for USC School of Cinematic Arts.
Show more
Investment focus
  • SaaS, Collectibles, Developer Platform
  • Series B, Seed, Series A
  • Canada, United States
Portfolio highlights
  • Dapper Labs — Dapper Labs uses the power of play to deliver blockchain-based experiences that are made for you and ready for the real world.
  • Mino Games — Mino Games is a free-to-play mobile gaming studio that produced the top 50 grossing mobile game Mino Monsters, with over 13 million downloads. We create deeply engaging, widely appealing games for millions of fans. We’re currently building our world class development studio in Montreal.We are a small group of passionate engineers, artists andanalysts with a mission to create games that millions of people all around the world love to play for years. We are funded by the best angel investors, institutional investors, and gaming companies from across the world.Our third and latest game, Cat Game, has already hit the App Store’s Top 100 Grossing Chart in Canada. The game, currently in soft launch, is showing world class key metrics, and we are expecting it to be a global hit when we launch it by February 2019.We are looking today to grow the team and looking for world class ambitious talent to come join us on the journey, to develop and support this newest title into a global success on both iOS and Android, and help us with future projects as we rapidly grow.
  • Epicrop Technologies — The only company using a nature-based epigenetic approach to enhance crops, accelerating development and delivering proven results.
Jonathan Milner Angel · Cambridge, Massachusetts, United States · 2 investments in the past 12 months
Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United Kingdom, United States, Canada
Portfolio highlights
  • Nuclera — Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. Nuclera has since grown to fifty-seven employees across two continents as the Company delivers on its founders’ vision to make biology accessible to everyone through desktop bioprinting. With desktop bioprinting, researchers and scientists will be empowered totake control of biology through streamlined access to a next-day supply of proteins and genes.
  • SolasCure — Our proprietary technology leverages biomimicry and evidence-based medicine to treat patients with chronic wounds.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Investors by industry
Investors by country
Angel Investors in United States by industry